clinicaltrialsarena15d
Cocrystal to extend enrolment in Phase IIa influenza inhibitor trial
The therapy is developed as a potential treatment for both pandemic avian and seasonal influenza A infections. Credit: Yurii_Yarema / Shutterstock. Cocrystal Pharma has announced its intent to extend ...
Pharmaceutical Technology17d
Coronavirus Disease 2019 (COVID-19) + influenza vaccine by Pfizer for Influenzavirus A Infections: Likelihood of Approval
Coronavirus Disease 2019 (COVID-19) + influenza vaccine is under clinical development by Pfizer and currently in Phase II for Influenzavirus A Infections.
Pharmaceutical Technology18d
Coronavirus Disease 2019 (COVID-19) + influenza vaccine by Pfizer for Influenzavirus B Infections: Likelihood of Approval
Coronavirus Disease 2019 (COVID-19) + influenza vaccine is under clinical development by Pfizer and currently in Phase II for Influenzavirus B Infections. According to GlobalData, Phase II drugs for ...